论文部分内容阅读
磺脲类口服降糖药(SU)在临床使用已逾80年。它已发展成为一个庞大的家族,现可列出由30多种不同化合物制成的300余种不同名称的磺脲类口服降糖药。本文重点在综述有关SU的作用机制及其临床应用近年来的新进展。
Sulfonylurea oral hypoglycemic agents (SU) in clinical use for more than 80 years. It has evolved into a huge family of more than 300 different sulfonylurea oral hypoglycemic agents of more than 30 different compounds. This article focuses on the review of the mechanism of SU and its clinical application of recent advances.